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DObjective: Bleeding is a potentially serious complication of aortic surgery. We report our experience with the
use of a periaortic bovine pericardial baffle to control intractable intraoperative bleeding.
Methods: All patients who underwent aortic root, ascending, or arch replacements between January 2002 and
April 2013 were reviewed. A bovine pericardial periaortic baffle was created to shunt shed blood into the right
atrium. The transverse sinus was sutured closed in patients undergoing primary sternotomy. Baffle recipients
were compared with the remaining patients undergoing aortic surgery. The Fisher exact test was used to deter-
mine statistical significance for categoric variables. Continuous variables were compared using the nonpara-
metric Wilcoxon rank-sum test. All factors with a P value less than .2 were considered for multivariate
logistic regression to determine independent associations with baffle use.
Results: A total of 413 patients were identified, of whom 23 received a baffle. Operative mortality for patients
receiving a baffle was 4% (1/23) compared with 6% (25/390) (P ¼ 1) for the remaining patients. Prolonged
ventilation was more common in the baffle recipients (P<.0005); otherwise, there were no differences in post-
operative morbidity. Multivariate analysis of all patients undergoing aortic surgery revealed infectious endocar-
ditis (P<.0005; odds ratio, 15.1; 95% confidence interval, 4.8-47.2), redo sternotomy (P<.0005; odds ratio,
11.9; 95% confidence interval, 4.1-34.1), and male gender (P ¼ .04; odds ratio, 4.6; 95% confidence interval,
1.1-19.3) to be predictive of baffle placement.
Conclusions: Patients requiring salvage periaortic pericardial baffle for intractable intraoperative hemorrhage
experienced an operative mortality similar to that in the remaining patients undergoing aortic surgery. Infectious
endocarditis requiring root replacement or reoperative aortic surgery should alert the surgeon to the potential
need for baffle placement, including prophylactic transverse sinus closure. (J Thorac Cardiovasc Surg
2014;148:151-5)Bleeding can be a serious and life-threatening complication
of aortic surgery. Mortality for aortic surgery complicated
by significant bleeding has been reported to be as high as
22%.1,2 For specific management problems, such as active
prosthetic endocarditis, mortality rates as high as 22% to
57%3-5 have been reported. Procedures complicated by
bleeding lead to prolonged ventilation, intensive care unit
length of stay, overall length of stay, and increased hospital
costs.6-8 In addition, increased blood and blood product use
associated with resuscitating these patients has been shown
to increase the incidence of postoperative infection and the
short- and long-term risk of death.9-11
To this end, numerous strategies have been developed
and significant resources invested to combat perioperative
coagulopathy and bleeding. A few examples includee Division of Cardiothoracic Surgery, Medical University of South Carolina,
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glues, and sealants13-15; and off-label use of recombinant
activated factor VII.16,17 These measures are variably
effective at stopping coagulopathic or minor surgical
bleeding, and significant negative side effects have been
reported for most of these strategies.18-20 In contrast to
coagulopathic bleeding, aortic surgery presents a relatively
unique situation in which major surgical bleeding may not
be reachable without physiologically unrealistic measures.
Further coagulopathy and myocardial ischemia may make
reinstitution of cardiopulmonary bypass, cardioplegic arrest,
and revision of an aortic repair unreasonable.
In 1978, Cabrol and colleagues21 described aortic root
replacement using an inclusion technique and routine anas-
tomosis of the reapproximated aortic aneurysm sac to the
right atrial appendage to control bleeding. Since then, there
have been several modifications of the Cabrol shunt.22-26
The widespread adoption of aortic resection,27 as opposed
to graft inclusion, has resulted in the lack of an aneurysm
sac to create the Cabrol shunt should major hemorrhage
occur. A more recent technique described by Posacioglu
and colleagues24 in 2002 has revitalized the shunt option
by creating a baffle over the ascending aorta using bovine
pericardium that decompresses arterial bleeding through
creation of a shunt to the right atrium. The purpose of thisrdiovascular Surgery c Volume 148, Number 1 151
FIGURE 1. Pericardial baffle procedure. SVC, Superior vena cava.
Adapted with permission from Ikonomidis JS. Surgery for aortic valve
endocarditis. Op Tech Thorac Cardiovasc Surg. 2011;16:226-41.
Abbreviations and Acronyms
CI ¼ confidence interval
CT ¼ computed tomography
OR ¼ odds ratio
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Darticle is to review a decade of experience with the pericar-
dial baffle procedure and to identify risk factors for severe
bleeding potentially requiring its use.
MATERIALS AND METHODS
We retrospectively reviewed all aortic root, ascending, and arch replace-
ments from January 2002 to April 2013. This study was approved by the
institutional review board of the Medical University of South Carolina,
and the need for individual consent was waived. Data were obtained
from review of the patient’s medical records and the institutional Society
of Thoracic Surgeons Adult Cardiac database.
Conventional methods were used to attempt to obtain hemostasis in all
patients. For those patients who had clear surgical bleeding that was not
accessible and for whom resumption of cardiopulmonary bypass was
thought to be contraindicated, an appropriately trimmed sheet of bovine
pericardium was used to create a baffle over the ascending aorta, sutured
to surrounding structures, and decompressed into the right atrium
(Figure 1). It is important to note that the floor of this space includes the
opening of the transverse sinus between the dome of the left atrium and
the right pulmonary artery. To obtain hemostasis, this communication
with the free pericardial space must be closed in primary sternotomy pa-
tients. Closure of the transverse sinus is most easily accomplished before
aortic reconstruction in cases in which the baffle may be anticipated.
Patients receiving a baffle were compared with those who did not. The
decision to place a baffle was at the discretion of the attending surgeon and
was made on the basis of the amount and location of bleeding after
adequate patient rewarming, separation from bypass, reversal of heparin,
and correction of coagulation deficiencies.
Categoric variables are reported as percentages, and the median is re-
ported for each continuous variable. Fisher exact test was used to determine
the statistical significance for categoric variables. Continuous variables
were compared using the nonparametric Wilcoxon rank-sum test. All fac-
tors with a univariate P value less than .2 were considered for multivariate
logistic regression to determine independent multivariate associations with
placement of a baffle.
RESULTS
Between January 2002 and April 2013, 413 patients un-
derwent aortic root, ascending, or arch replacement. Preop-
erative demographics are listed in Table 1. Baffle recipients
had a higher incidence of previous sternotomy, infectious
endocarditis, and renal failure. Operative variables and out-
comes are listed in Table 2. Operative variables, including
the use of a homograft, bypass time, and crossclamp time,
were all significantly higher in the baffle group. Circulatory
arrest was less common in baffle recipients, and circulatory
arrest times were not statistically different. Postoperative
variables and outcomes, including open chest, prolonged
ventilation, and atrial fibrillation, were more common in
the baffle group. Of these 413 patients, 23 required a baffle
to control bleeding. There was 1 intraoperative death (4%)
among the baffle recipients, which was similar to the 25152 The Journal of Thoracic and Cardiovascular Surg(6%) in the remaining aortic surgery cohort (P ¼ 1.0).
The incidence of reoperation for bleeding, mediastinitis,
permanent stroke, renal failure, and death was similar be-
tween the 2 groups.
On multivariate analysis of the entire aortic surgery
cohort, preoperative predictors of baffle placement included
infectious endocarditis (P<.0005; odds ratio [OR], 15.1;
95% confidence interval [CI], 4.8-47.2), redo operation
(P<.0005; OR, 11.9; 95% CI, 4.1-34.1), and male gender
(P ¼ .04; OR, 4.6; 95% CI, 1.1-19.3). The receiver oper-
ating curve for this analysis yielded a C statistic of 0.87
(95% CI, 0.80-0.95).
Of the 22 baffle survivors, postoperative imaging was
available for 20 patients. Fifteen patients underwent com-
puted tomography (CT), and 5 patients underwent transtho-
racic echocardiography. Six patients were found to have
persistent flow within the baffle. Of these, 5 patients had un-
dergone homograft root replacement for prosthetic endocar-
ditis and 1 patient underwent redo sternotomy for Stanford
type A aortic dissection with aortic root, ascending, and
hemiarch replacement using a bioprosthetic valved conduit.
One patient required reintervention, and the remainder were
asymptomatic.DISCUSSION
Aside from the efforts of Cabrol and colleagues,21 subse-
quent reports of shunts in this setting have been limited toery c July 2014
TABLE 1. Demographics and risk factors
Baffle
(n ¼ 23)
No baffle
(n ¼ 390) P
Age (median)
Range
63 y
35-81 y
60 y
19-86 y
.835
Gender (male) 20 (87%) 261 (67%) .063
Dissection 5 (22%) 87 (22%) 1.000
Redo operation 17 (74%) 57 (15%) <.0005
Infectious endocarditis 11 (48%) 14 (4%) <.0005
Preoperative renal failure 3 (13%) 8 (2%) .019
Hypertension 14 (61%) 283 (73%) .237
Preoperative antiplatelets 0 8 (2%) 1.000
Preoperative anticoagulants 3 (13%) 53 (14%) 1.000
Preoperative ASA 9 (39%) 142 (36%) .826
ASA, Acetylsalicylic acid.
TABLE 2. Operative variables and outcomes
Operative variables
Baffle
(n ¼ 23)
No baffle
(n ¼ 390) P
Homograft 13 (57%) 14 (4%) <.0005
Bypass time (median) 239 min
142-421 min
161 min
68-496 min
<.0005
Crossclamp time 123 min
71-250 min
108 min
0-327 min
.001
Circulatory arrest 7 (30%) 293 (75%) <.0005
Circulatory arrest time 13 min
11-55 min
12 min
4-66 min
.216
Lowest core temperature 27C
16C-34C
20C
14C-36C
<.0005
Outcomes
Open 6 (26%) 14 (4%) <.0005
Reoperation for bleeding 3 (13%) 24 (6%) .183
Mediastinitis 0 2 (0.5%) 1.000
Ventilation prolonged (>24 h) 15 (65%) 102 (26%) <.0005
Permanent stroke 0 15 (4%) 1.000
Postoperative renal failure
(excluding history of renal
failure preoperatively)
2 (9%) 22 (6%) .635
Atrial fibrillation 10 (44%) 88 (23%) .039
Operative death 1 (4%) 25 (6%) 1.000
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The size of this series allows for statistical analysis and
identification of risk factors associated with baffle
placement. Risk factor identification is important because
closure of the transverse sinus is essential for hemostasis.
This is accomplished by approximation of the dome of the
left atrium and the right pulmonary artery by direct suture
approximation or using a small autologous or bovine
pericardial patch. This anatomy is most easily visualized
after aneurysm resection but before aortic reconstruction.
Because these structures reside in the most dependent
portion of the operative field, visualization of this area can
become difficult if significant bleeding occurs after
crossclamp removal. Thus, closure of the transverse sinus
should be performed before aortic reconstruction in
patients with risk factors for severe bleeding.
Cabrol’s27 prophylactic use of a shunt during aortic root
replacement resulted in a total of 260 shunted patients. Of
these, he reported that 3 had persistent flow.27 One was
asymptomatic, and the other 2 required reoperation.Although
the number of patients who would have required shunt
placement for severe bleeding is unknown, this experience
suggests that the majority spontaneously thrombose and
reintervention is uncommon.
In 1987, Hoover and colleagues22 described alternative
techniques to shunt blood from within the aneurysm sac
to the right atrium or innominate vein by way of a 6-mm
polytetrafluoroethylene (Gore-Tex;WLGore &Associates,
Inc, Flagstaff, Ariz) graft. In this report, 9 of 33 patients
undergoing aortic root surgery required creation of a shunt
to control bleeding. Of these, 2 remained patent. One was
asymptomatic, and the second required reoperation for
congestive heart failure. There were no deaths in this series.
Many have abandoned the inclusion technique in favor of
complete aortic resection after this was shown to reduce
complication rates.28 After resection and replacement of
the aneurysmal aorta, the surrounding natural anatomic
structures are all that remain to form the boundaries of theThe Journal of Thoracic and Cashunt. The area surrounding the ascending aorta can be
made hemostatic by suturing a pericardial baffle over these
structures, closing the transverse sinus, and decompressing
the shunt directly into the right atrial appendage or via a
vascular graft to the right atrial free wall or innominate
vein.25 Posacioglu and colleagues24 reported 7 such shunts
in a series of 109 patients undergoing repair of Stanford
type A aortic dissection. Their technique used autologous
or bovine pericardium to baffle shed periaortic blood into
the right atrium. All patients survived, and there were no
persistent patent fistulae on transthoracic echocardiography
or CT scan before discharge.We observed a similar outcome
in our patient cohort using this baffle modification.
The current series was accomplished using the technique
described by Posacioglu and colleagues24 for all 23 cases.
The observed mortality rate of 4% for baffle recipients
was no different than that of the remaining cohort of pa-
tients undergoing aortic surgery. This is remarkable given
that this subset of high-risk patients have mortality rates re-
ported as high as 22% to 57%,3-5 depending on the surgical
indication. Furthermore, despite the salvage nature of this
procedure, 74% of patients in this series underwent
primary chest closure. Although prolonged ventilation
was more common in the baffle recipients, the incidence
of reoperation for bleeding, mediastinitis, stroke, and post-
operative renal failure was similar. In this experience,
deployment of a baffle converted cases heading toward
significant morbidity and a high likelihood of mortality to
a relatively routine postoperative course.rdiovascular Surgery c Volume 148, Number 1 153
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DNotable in this series was the low incidence of reinterven-
tion for persistent fistula. Of the 6 persistent fistulae found
on postoperative CT, 1 has required reintervention. This
patient initially underwent a redo sternotomy for gram-
negative prosthetic endocarditis involving a homograft
root replacement. At the time of surgery, there was exten-
sive annular destruction with ventriculoaortic separation.
The homograft was replaced, and a baffle was required
for hemostasis. On serial CT imaging, the fistula gradually
thrombosed leaving a small posterior pseudo-aneurysm.
There was no evidence of recurrent infection. This was
medically managed over the next 12 months until slow
enlargement led to angina from compression of the left
main coronary artery. The patient underwent successful
percutaneous closure of the pseudoaneurysm with an Am-
platzer muscular ventricular septal defect occluder (AGA
Medical, Golden Valley, Minn).29
Volume overload of the right ventricle and subsequent
heart failure are theoretic concerns after baffle placement.
In the current series, no patients required reoperation for
heart failure. The rate of bleeding was not recorded but
was found to range from 175 to 350 mL/min 30 minutes af-
ter protamine administration in Hoover and colleagues’ se-
ries of 9 patients.22 As pointed out in the ‘‘Discussion’’ of
that article, even massive rates of bleeding account for a
small fraction of the cardiac output. In the current series,
1 baffle recipient died of post-cardiotomy shock after ho-
mograft root replacement for prosthetic valve endocarditis.
This case was long and complicated by coronary insuffi-
ciency, proximal anastomotic bleeding, and biventricular
failure. Volume overload of the right ventricle could not
be clearly implicated or excluded in this outcome.
Premature fistulae thrombosis also is a potential concern.
In this experience, tamponade physiology developed in 1
patient immediately after completion of the baffle. The
baffle pressurized and bled from all epicardial suture lines,
indicating inadequate right atrial runoff. The baffle was
incised and reopened. A 3-cm–long piece of 36F chest
tube was used to stent the atriotomy open. A silk tie was
secured around the chest tube segment and externalized
through the baffle suture line to facilitate removal at a later
date. Ultimately, the source of hemorrhage resolved and the
fistula thrombosed. The chest tube was safely removed at
chest closure 48 hours later. Alternatively, as described by
Hoover and colleagues,22 a vascular graft from the baffle
to the right atrium or innominate vein may have prevented
this problem.
Although 5 of 6 patients found to have persistent fistulae
had undergone homograft root replacements for prosthetic
endocarditis with extensive annular destruction, not all
bleeding was from the proximal suture line. In 1 of these
5 patients, the right pulmonary artery was densely adherent
to the posterior aorta, and the patient had an iatrogenic
injury during dissection. This was primarily repaired, but154 The Journal of Thoracic and Cardiovascular Surgthese tissues were friable and after separation from bypass
bled significantly. Pericardial patch repair or interposition
graft would have been required to control the bleeding.
The affected area was immediately behind the homograft
and could not be adequately exposed without taking down
the distal anastomosis. Given the length of time required
to complete the operation, it was opted not to reinstitute car-
diopulmonary bypass to attempt this repair. A baffle was
used, and the procedure was completed without incident.
Given the relatively low pressure of this system, it was
thought to be low risk for persistent fistula. On follow-up
CT, however, right pulmonary artery to right atrium contrast
flow was evident. The patient remains asymptomatic.
The left main coronary button anastomosis was found to
be the source of a persistent fistula in a patient requiring a
baffle for hemostasis after redo sternotomy and replacement
of the aortic root, ascending, and hemiarch with a bio-
prosthetic valved conduit. The patient presented with a
Stanford type A aortic dissection and was approximately
10 years out from a mechanical aortic valve replacement
for a bicuspid aortic valve. Intraoperatively, the source of
bleeding could not be identified and was presumed to be
the proximal anastomosis. Postoperative CT scan clearly
demonstrated the inferior margin of the left main button
to be the source of the fistula. The patient remains asymp-
tomatic with continuous murmur on physical examination.
Extreme caution should be exercised deploying a pericar-
dial baffle in the setting of coronary artery bypass grafts and
in patients undergoing concomitant mitral valve proce-
dures. We have deployed the baffle in the setting of bypass
grafts by leaving a large gap (1-1.5 cm) in the pericardial su-
ture line as it passes over the graft while maintaining tight
spacing on the right ventricular outflow tract to create a
pericardial wrap around the vein graft. We have found
that this forms a longitudinal fold in the pericardium 1.5
to 2 cm long, thereby creating a large area of coaptation
with the graft. Because of this, the pericardium will main-
tain hemostasis but does not need to be tightly wrapped
around the vein graft. Patients undergoing a concomitant
mitral valve procedure with extensive dissection along the
dome of the left atrium or under the superior vena cava
for mobilization, exposure, or caval snaring will have
communications with the pericardial space other than the
transverse sinus. These need to be closed before baffle
placement.
Study Limitations
This study is retrospective, involved multiple surgeons,
and is subject to their respective preferences and biases.
Long-term follow-up of these patients is unavailable. The
rate of blood loss before baffle placement was not recorded.
There were no uniform indications or criteria for baffle
placement. Strategies to cope with intraoperative bleeding,
including the use of aprotinin and recombinant activatedery c July 2014
Toole et al Acquired Cardiovascular Diseasefactor VII, evolved significantly over the study period. Use
of a homograft for aortic root replacement is reserved for se-
vere cases of endocarditis with extensive annular tissue
destruction at the Medical University of South Carolina. In-
fectious endocarditis may not be an accurate predictor of
baffle requirement at institutions with more liberal criteria
for homograft use. Although routine CT follow-up of pa-
tients undergoing aortic surgery before discharge is the
standard at the Medical University of South Carolina,
only 15 of 22 survivors completed this study. The adequacy
of transthoracic echocardiography for detecting persistent
fistulae is unknown.A
C
DCONCLUSIONS
A periaortic pericardial baffle can be lifesaving during
ascending aortic surgery complicated by severe bleeding.
In this series, use of a pericardial baffle normalized in-
hospital mortality. Seventy-four percent of patients under-
went primary chest closure and resumed a relatively routine
postoperative course. The majority of shunts thrombosed.
Patent shunts were well tolerated, and reintervention for
persistent flow was uncommon. Endocarditis requiring
aortic root replacement and redo sternotomy were predic-
tive of baffle placement and should prompt proactive
consideration of this technique, including prophylactic
closure of the transverse sinus.References
1. Kouchoukos NT, Wareing TH. Management of complications of aortic surgery.
In: Waldhausen JA, Orringer MB, eds.Complications in Cardiothoracic Surgery.
St. Louis, MO: Mosby; 1991:221-36.
2. Unsworth-White MJ, Herriot A, Valencia O, Poloniecki S, Smith EE,
Murday AJ, et al. Resternotomy for bleeding after cardiac operation: a marker
for increased morbidity and mortality. Ann Thorac Surg. 1995;55:664-7.
3. Lytle BW, Priest BP, Taylor PC, Loop FD, Sapp SK, Stewart RW, et al. Surgical
treatment of prosthetic valve endocarditis. J Thorac Cardiovasc Surg. 1996;111:
198-207.
4. Baumgartner WA, Miller DC, Reitz BA, Oyer PE, Jamieson SW, Stinson ER,
et al. Surgical treatment of prosthetic valve endocarditis. Ann Thorac Surg.
1983;35:87-104.
5. Jones JM, O’Kane H, Gladstone DJ, SarsamMA, Campalani G, MacGowan SW,
et al. Repeat heart valve surgery: risk factors for operative mortality. J Thorac
Cardiovasc Surg. 2001;122:913-8.
6. Christensen M, Krapf S, Kempell A, van Heyman C. Costs of excessive
post-operative hemorrhage in cardiac surgery. J Thorac Cardiovasc Surg.
2009;138:687-93.
7. Doering LV, Esmailian F, Laks H. Perioperative predictors of ICU and hospital
costs in coronary artery bypass graft surgery. Chest. 2000;118:736-43.
8. Murphy GJ, Reeves BC, Rogers CA, Rizvi SI, Culliford L, Angeline GD.
Increased mortality, postoperative morbidity, and cost after red blood cell
transfusion in patients having cardiac surgery. Circulation. 2007;116:2544-52.
9. Chelemer SB, Prato S, Cox PM, O’Connor GT, Morton JR. Association of
bacterial infection and red blood transfusion after coronary artery bypass surgery.
Ann Thorac Surg. 2002;73:138-42.The Journal of Thoracic and Ca10. Koch CG, Li L, Duncan AI, Mihaljevic T, Cosgrove DM, Loop FD, et al.
Morbidity and mortality risk associated with red blood cell and blood component
transfusion in isolated coronary artery bypass grafting. Crit Care Med. 2006;34:
1608-16.
11. Karkouti K, Wijeysundera DN, Yau TM, Beattie WS, Abdelnaem E,
McClusky SA, et al. The independent association of massive blood loss with
mortality in cardiac surgery. Transfusion. 2004;44:1453-62.
12. Karski JM, Teasdale SJ, Norman P, Carroll J, Vankessel K, Wong P, et al.
Prevention of bleeding after cardiopulmonary bypass with high dose tranexamic
acid. J Thorac Cardiovasc Surg. 1995;110:842.
13. Oz MC, Rondinone JF, Shargill NS. Floseal matrix: new generation topical
hemostatic sealant. J Card Surg. 2003;18:486-93.
14. Oz MC, Cosgrove DM III, Badduke BR, Hill JD, Flannery MR, Palumbo R, et al.
Controlled clinical trial of a novel hemostatic agent in cardiac surgery. Ann
Thorac Surg. 2000;69:1376-82.
15. Kheirabadi BS, Field-Ridley A, Pearson R, MacPhee M, Drohan W, Tuthill D.
Comparative study of the efficacy of the common topical hemostatic agents
with fibrin sealant in a rabbit aortic anastomosis model. J Surg Res. 2002;106:
99-107.
16. Bowman LJ, Uber WE, Stroud MR, Christiansen LR, Lararchick, Crumbley AJ,
et al. Use of recombinant activated factor VII concentrate to control postoperative
hemorrhage in complex cardiovascular surgery. Ann Thorac Surg. 2008;85:
1669-77.
17. Uber WE, Toole JM, Stroud MR, Haney JS, Lazarchick J, Crawford FA Jr, et al.
Administration of recombinant activated factor VII in the intensive care unit after
complex cardiovascular surgery: clinical and economic outcomes. J Thorac
Cardiovasc Surg. 2011;141:1469-77.
18. Ngaage DL, Edwards WD, Bell MR, Sundt TM. A cautionary note regarding
long-term sequelae of biologic glue. J Thorac Cardiovasc Surg. 2005;129:937-8.
19. Fergusson DA, Herbert PC, Mazar CD, Fremes S, MacAdams C, Murkin JM,
et al. A comparison of aprotinin and lysine analogues in high risk cardiac surgery.
N Engl J Med. 2008;358:2319-31.
20. Gill R, Herbertson M, Vuylsteke A, Olsen PS, von Heymann C, Mythen M, et al.
Safety and efficacy of recombinant activated factor vii a randomized
placebo-controlled trial in the setting of bleeding after cardiac surgery. Circula-
tion. 2009;120:21-7.
21. Cabrol C, Pavie A, Gandjbakh CH, Villemot JP, Guiraudon G, Laughlin L, et al.
Complete replacement of the ascending aorta with re-implantation of the
coronary arteries; a new surgical approach. J Thorac Cardiovasc Surg. 1981;
81:209-15.
22. Hoover EL, Hsu HK, Ergin A, Ketosugbo A, Webb H, Kharma B, et al. Left to
right shunt in control of bleeding following surgery for aneurysm of the
ascending aorta. Chest. 1987;91:884.
23. Blum M, Panos A, Lichtenstein SV, Salerno TA. Modified Cabrol shunt for
control of hemorrhage in repair of type A dissection. Ann Thorac Surg. 1989;
48:709-11.
24. Posacioglu H, Apaydin AZ, Calkavur T, Yagdi T, Islamoglu F. Perigraft to right
atrial shunt by using autologous pericardium for control of bleeding in acute type
A dissections. Ann Thorac Surg. 2002;74:1071-4.
25. Salerno TA, Carvalho EM, Panos AL, Ricci M. Modified Cabrol shunt after
complex aortic surgery. Ann Thorac Surg. 2008;86:669-70.
26. Elefteriades JA, Youssef S, Rousou L, Nazer R. Novel valved graft modification
of Cabrol fistula for bleeding after aortic surgery. Ann Thorac Surg. 2012;94:
1741-3.
27. Cabrol C. Invited commentary of Mancini MC, Cush EM. Shunt control of
bleeding after homograft replacement of the ascending aorta. Ann Thorac
Surg. 1999;67:1162-3.
28. Kouchoukos NT, Marshall WG, Wedige-Stecher TA. Eleven year experience
with composite graft replacement of the ascending aorta and aortic valve.
J Thorac Cardiovasc Surg. 1986;92:691-705.
29. Graham EM, Bandisode VM, Atz AM, Kline CH, Taylor MH, Ikonomidis JS.
Percutaneous occlusion of a pseudoaneurysm evolving after homograft aortic
valve and root replacement using the Amplatzer muscular VSD occluder.
J Thorac Cardiovasc Surg. 2006;131:914-6.rdiovascular Surgery c Volume 148, Number 1 155
